Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Raw Materials: 2019-2024

Historic Raw Materials for CorMedix (CRMD) over the last 2 years, with Dec 2024 value amounting to $1.1 million.

  • CorMedix's Raw Materials rose 1062.75% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 1062.75%. This contributed to the annual value of $1.1 million for FY2024, which is N/A change from last year.
  • CorMedix's Raw Materials amounted to $1.1 million in FY2024, which was up 16,023.73% from $6,893 recorded in FY2019.
  • In the past 5 years, CorMedix's Raw Materials ranged from a high of $1.1 million in FY2024 and a low of $1.1 million during FY2024.
  • Its 1-year average for Raw Materials is $1.1 million, with a median of $1.1 million in 2024.